White label ELPA - ClinicalTrials.eu

Study of Different Dosing Schedules of Osimertinib in Patients with EGFR Mutated Advanced or Metastatic Non-Small Cell Lung Cancer

Recruiting

3 1 1 1
Investigated Diseases:
- Non-small cell lung cancer metastatic
Investigated Drugs:
- Osimertinib
A study testing tenecteplase given directly into the artery after blood clot removal in patients with acute ischemic stroke in the front part of the brain

Recruiting

2 1 1
Investigated Diseases:
- Ischaemic stroke
Investigated Drugs:
- Tenecteplase
A Study of IMVT-1402 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy to Prevent Disease Relapse

Recruiting

2 1
Investigated Diseases:
- Chronic inflammatory demyelinating polyradiculoneuropathy
Investigated Drugs:
- IMEROPRUBART
+13
A study comparing BNT323 with chemotherapy in patients with HER2-expressing recurrent endometrial cancer who received previous treatment

Recruiting

3 1 1 1
Investigated Diseases:
- Endometrial cancer
- Endometrial cancer recurrent
Investigated Drugs:
+9
A Study of Mezagitamab Compared to Placebo for Adults with Chronic Primary Immune Thrombocytopenia

Recruiting

3 1

+6
Study of Methotrexate Treatment for Patients with Erosive Hand Osteoarthritis Not Responding to Standard Therapy

Recruiting

2 1 1
Investigated Drugs:
Study of antibiotic treatment effectiveness in critically ill patients receiving drug combination therapy

Recruiting

3 1 1 1
Investigated Drugs:
Study of Platelet-Rich Plasma Injections Combined with Exercise Compared to Betamethasone and Ropivacaine for Chronic Shoulder Pain Treatment

Recruiting

3 1 1 1
Investigated Drugs:
Study of methadone and morphine combination for pain relief in patients with bone metastases from cancer

Recruiting

3 1 1
Investigated Diseases:
- Cancer pain
Investigated Drugs:
- Methadone Hydrochloride
- Morphine Sulfate
Study of BNT326 alone and with BNT327 in patients with advanced solid tumors: Testing safety and effectiveness of new cancer treatments

Recruiting

1 1 1
Investigated Drugs:
- BNT327

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies